TMEM48 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.703800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.521000E-01
Normal-vs-Stage2
7.662400E-01
Normal-vs-Stage3
2.204800E-01
Normal-vs-Stage4
5.420600E-01
Stage1-vs-Stage2
7.453000E-01
Stage1-vs-Stage3
2.595000E-01
Stage1-vs-Stage4
5.004200E-01
Stage2-vs-Stage3
1.438450E-01
Stage2-vs-Stage4
5.119200E-01
Stage3-vs-Stage4
1.383980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.729200E-01
Normal-vs-AfricanAmerican
9.185200E-01
Normal-vs-Asian
9.560800E-01
Caucasian-vs-AfricanAmerican
9.201800E-01
Caucasian-vs-Asian
8.393600E-01
AfricanAmerican-vs-Asian
9.589000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.792000E-01
Normal-vs-Female
7.437800E-01
Male-vs-Female
1.254350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.926000E-01
Normal-vs-Age(41-60Yrs)
6.787800E-01
Normal-vs-Age(61-80Yrs)
9.881200E-01
Normal-vs-Age(81-100Yrs)
7.440000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.444200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.106600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.335800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.386370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.412200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.779800E-01
Normal-vs-Daily Drinker
9.741800E-01
Normal-vs-Weekly Drinker
8.218000E-01
Normal-vs-Occasional Drinker
6.295000E-01
Normal-vs-Social Drinker
7.475800E-01
Non Drinker-vs-Daily Drinker
6.553000E-01
Non Drinker-vs-Weekly Drinker
4.791600E-01
Non Drinker-vs-Occasional Drinker
7.115200E-01
Non Drinker-vs-Social Drinker
8.894400E-01
Daily Drinker-vs-Weekly Drinker
7.755800E-01
Daily Drinker-vs-Occasional Drinker
3.448000E-01
Daily Drinker-vs-Social Drinker
5.144600E-01
Weekly Drinker-vs-Occasional Drinker
2.161800E-01
Weekly Drinker-vs-Social Drinker
3.583200E-01
Occasional Drinker-vs-Social Drinker
8.321800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.222000E-01
Normal-vs-Grade 2
4.098800E-01
Normal-vs-Grade 3
4.185200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.441760E-03
Grade 1-vs-Grade 3
9.783300E-04
Grade 1-vs-Grade 4
9.222000E-01
Grade 2-vs-Grade 3
2.308000E-01
Grade 2-vs-Grade 4
4.098800E-01
Grade 3-vs-Grade 4
4.185200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.679800E-01
Normal-vs-NonDiabetic
9.762000E-01
Diabetic-vs-NonDiabetic
5.253000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.618800E-01
Normal-vs-NoPancreatitis
9.377000E-01
Pancreatitis-vs-NoPancreatitis
5.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.464800E-01
Normal-vs-N1
7.578800E-01
N0-vs-N1
1.920020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.459600E-01
Normal-vs-TP53-NonMutant
8.860800E-01
TP53-Mutant-vs-TP53-NonMutant
1.978480E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
